Amenorrhea

Approved for this indication (6)

• progesterone
• medroxyprogesterone
• progestoral
• gonadorelin
• norethindrone
• fosfestrol sodium

Phase 4 trials (9)

• vitamin d3
• norgestrel
• tibolone
• calcium carbonate
• ethinyl estradiol
• leuprolide
• sitagliptin
• cyproviron
• lutropin alpha

Phase 3 trials (4)

• romosozumab
• platelet-rich plasma
• zoledronic acid
• estrogen

Phase 2 trials (9)

• asoprisnil
• conjugated equine estrogens
• hemopoietic stem cell
• metreleptin
• kisspeptin
• progestin
• progenta
• estradiol
• levonorgestrel

Other trials (4)

• beetroot juice
• myoinositol
• starch
• estrone

Organization Involved with Phase 4 Indications (6)

• Merck Serono
• Solvay
• Fundação Educacional Serra dos Órgãos
• Central South University
• University of Cagliari
• University Reproductive Associates

Organization Involved with Phase 3 Indications (9)

• National Institutes of Health (NIH)
• TherapeuticsMD
• Harvard University
• University of Athens
• Tsinghua University
• University of Sherbrooke
• CSSS Chicoutimi
• Ferring
• University of Picardie Jules Verne

Organization Involved with Phase 2 Indications (9)

• Abbott
• Amgen
• TAP Pharmaceuticals
• Duramed Research
• National Center for Research Resources (NCRR)
• Cedars-Sinai Medical Center
• University of Texas at Houston
• Repros Therapeutics
• ICON

Organization Involved with Other Experimental Indications (2)

• Assiut University
• Catholic University of Sacred Heart, Rome